WASHINGTON, March 1 -- The American Association of People with Disabilities has submitted a public comment letter to the U.S. Department of Health and Human Services expressing serious concerns regarding a proposed rule that would impact hospitals' participation in Medicare and Medicaid programs. The AAPD advocates for the civil rights of over 70 million Americans with disabilities, emphasizing the importance of access to necessary medical care. The proposed changes would prohibit hospitals fro more ST

WASHINGTON, March 1 -- AARP has submitted a public comment letter to the Centers for Medicare & Medicaid Services urging the federal agency to prioritize initiatives aimed at making prescription drugs more affordable for older Americans. With 125 million members aged 50 and older, AARP has long championed the cause of reducing prescription drug costs, particularly as these expenses have become burdensome for many seniors. The letter, signed by Megan O'Reilly, Vice President, Health and Family G more ST

WASHINGTON, March 1 -- The Advocacy Council of the American College of Allergy, Asthma and Immunology has expressed its concerns in a public comment letter to the Centers for Medicare and Medicaid Services regarding the proposed Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model. The organization, representing over 6,000 allergists-immunologists and allied health care professionals, emphasizes the need for careful scrutiny of the potential unintended consequences of the model, aimed  more ST

WASHINGTON, March 1 -- The Academy of Managed Care Pharmacy has submitted a public comment letter to the Centers for Medicare & Medicaid Services voicing several concerns regarding the proposed Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model. AMCP, a professional association dedicated to enhancing access to affordable medications, emphasized the need for careful scrutiny of the model's operational feasibility and its potential impact on beneficiaries. In the letter, signed by Sus more ST

WASHINGTON, March 1 -- The ACLU of Illinois has submitted a public comment letter to the Centers for Medicare and Medicaid Services (CMS), urging the federal agency to reconsider its Proposed Rule CMS-3841-P, which seeks to limit participation in Medicare and Medicaid programs for hospitals that perform sex trait modification procedures on children. The organization contends that if implemented, this rule will severely restrict access to gender-affirming care for transgender minors and undermine more ST

WASHINGTON, March 1 -- The American Hospital Association has submitted a public comment letter to the Centers for Medicare & Medicaid Services expressing its support for efforts to lower prescription drug prices through the proposed Global Benchmark for Efficient Drug Pricing (GLOBE) Model. However, the organization has raised critical concerns about the potential operational challenges and administrative burdens that the model could impose on hospitals and health systems. In its letter, the AH more ST

WASHINGTON, March 1 -- Aimed Alliance, a non-profit health policy organization focused on the rights of health care consumers and providers, has issued a public comment letter to the Centers for Medicare and Medicaid Services (CMS) expressing concerns over the proposed GLOBE Model for drug pricing in Medicare Part B. While acknowledging CMS's efforts to lower prescription drug costs, the letter, signed by Ashira Vantrees, Director of Legal Strategy & Advocacy, argues that the GLOBE Model may n more ST

WASHINGTON, March 1 -- The Alliance for Fair Health Pricing submitted a public comment letter to the U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services, the U.S. Department of the Treasury, and the U.S. Department of Labor, emphasizing the dire need for enhanced price transparency in health care. The organization expressed its support for initiatives aimed at lowering health care costs for patients, employers, and taxpayers amid escalating prices that have le more ST

WASHINGTON, March 1 -- The Alliance for Patient Access has submitted a public comment letter to the Centers for Medicare & Medicaid Services expressing deep concerns regarding the proposed Global Benchmark for Efficient Drug Pricing (GLOBE) Model. This initiative aims to implement a pricing strategy for certain Medicare Part B drugs using international drug pricing data, which AfPA argues could have detrimental effects on patient care and access. AfPA, a national network founded in 2006 that ad more ST

WASHINGTON, March 1 -- Alnylam Pharmaceuticals Inc. has submitted a public comment letter to the Centers for Medicare & Medicaid Services regarding the proposed Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model. In their communication, Alnylam, a leader in RNA interference therapeutics, expressed support for comments made by several industry organizations including the Biotechnology Innovation Organization and the Mid-sized Biotech Alliance of America, all voicing apprehension regar more ST

WASHINGTON, March 1 -- AMAC Action, the advocacy affiliate of the Association of Mature American Citizens, submitted a public comment letter to the Centers for Medicare & Medicaid Services expressing support for proposed updates to the Transparency in Coverage requirements. With a membership exceeding 2 million nationwide, AMAC Action emphasizes the importance of clear healthcare pricing for seniors living on fixed incomes. In the letter, Andrew J. Mangione Jr., Senior Vice President, commends  more ST

WASHINGTON, March 1 -- Ambros Therapeutics, a clinical-stage biotechnology company, has submitted a public comment letter to the Centers for Medicare & Medicaid Services expressing opposition to the proposed Global Benchmark for Efficient Drug Pricing (GLOBE). The company argues that the model, aimed at implementing international reference pricing for Medicare Part B beneficiaries, poses significant risks and uncertainties in the U.S. reimbursement landscape. In its comments, Ambros highlights  more ST

WASHINGTON, March 1 -- America's Future Inc., a nonprofit organization focused on policy advocacy, submitted a public comment letter to the Centers for Medicare and Medicaid Services in strong support of a proposed rule prohibiting sex-rejecting procedures for children. The organization argues that the proposed regulation is essential for the health and safety of minors and reflects a growing public concern regarding the risks associated with irreversible medical interventions. The letter signe more ST

WASHINGTON, March 1 -- The American Academy of Neurology has addressed a public comment letter to the Centers for Medicare & Medicaid Services expressing strong support for the Global Benchmark for Efficient Drug Pricing (GLOBE) Model aimed at reducing out-of-pocket (OOP) costs for Medicare beneficiaries. With over 44,000 members, the AAN represents the interests of neurologists and neuroscience professionals and is a leading advocate for brain health. In their communication, the AAN outlined t more ST

WASHINGTON, March 1 -- The American Academy of Ophthalmology has submitted a public comment letter to the Centers for Medicare and Medicaid Services regarding the proposed Global Benchmark for Efficient Drug Pricing (GLOBE) Model. The letter expresses the Academy's appreciation for the opportunity to provide insights on this critical issue. As the largest association of eye physicians and surgeons in the U.S., the Academy comprises over 20,000 medical doctors dedicated to protecting sight and i more ST

WASHINGTON, March 1 -- The American Pharmacists Association has submitted a public comment letter to the U.S. Department of Health and Human Services regarding the proposed rule on "Transparency in Coverage." APhA is advocating for increased price transparency to aid patients in making well-informed healthcare decisions. Representing a diverse range of pharmacy professionals, including pharmacists and pharmacy technicians across various practice settings, APhA emphasizes in a letter signed by M more ST

WASHINGTON, March 1 -- The American Plasma Users Coalition has submitted a public comment letter to the Centers for Medicare & Medicaid Services calling for the exclusion of plasma-derived therapies from the proposed Global Benchmark for Efficient Drug Pricing (GLOBE) Model. The organization represents over 125,000 individuals with rare and chronic disorders who heavily rely on plasma protein therapies. APLUS warns that incorporating these therapies into the GLOBE Model could lead to critical s more ST

WASHINGTON, March 1 -- AnewHealth, a pharmacy services provider, has submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS) concerning the proposed Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model. Published in late December 2025, this model aims to scrutinize Medicare drug spending by mandating manufacturer rebates when U.S. prices for specific drugs surpass those in economically comparable countries. AnewHealth highlighted its support for CMS's i more ST

WASHINGTON, March 1 -- The American Public Health Association, along with 122 public health and health policy leaders, has submitted a public comment letter opposing the Centers for Medicare & Medicaid Services' proposed rule to prohibit hospitals from receiving Medicare and Medicaid reimbursements if they offer puberty blockers, hormone therapy, or surgeries to transgender youth under age 18. This proposed rule, they argue, contravenes constitutional protections and the intent of Medicare and M more ST

WASHINGTON, March 1 -- Ardelyx Inc., a biopharmaceutical firm headquartered in Waltham, Massachusetts, has submitted a public comment letter to the Centers for Medicare and Medicaid Services (CMS) expressing strong opposition to the proposed "Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model." The company warns that importing foreign reference pricing into the United States could have detrimental consequences for small and midsize biopharmaceutical companies, as well as patients rec more ST

WASHINGTON, March 1 -- The American Speech-Language-Hearing Association has submitted a public comment letter to the Centers for Medicare & Medicaid Services expressing strong opposition to a proposed rule that would prohibit sex-rejecting procedures for children. This regulation would significantly affect the ability of licensed health care professionals, including speech-language pathologists, to deliver essential services within their scopes of practice. ASHA, representing 241,000 members an more ST

WASHINGTON, March 1 -- The Association of Nurses in AIDS Care has issued a public comment letter to the U.S. Department of Health and Human Services, expressing strong opposition to a proposed rule that would prohibit coverage of specific gender-affirming services for individuals experiencing gender dysphoria under the Medicaid program and Children's Health Insurance Program (CHIP). The organization, which has been dedicated to addressing the needs of healthcare professionals involved in HIV/AID more ST

WASHINGTON, March 1 -- Autolus Therapeutics plc has submitted a public comment letter to the Centers for Medicare & Medicaid Services concerning the proposed Global Benchmark for Efficient Drug Pricing Model. The company aims to highlight the necessity of an exemption for cell and gene therapy products within this initiative. Autolus is a biopharmaceutical company focused on developing advanced T cell therapies to combat cancer and autoimmune diseases. Its flagship product, AUCATZYL, which rece more ST

WASHINGTON, March 1 -- BioNJ, a trade association representing over 400 member entities in the life sciences sector, has submitted a public comment letter to the Centers for Medicare and Medicaid Services. The letter addresses grave concerns regarding the Global Benchmark for Efficient Drug Pricing (GLOBE) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Models proposed by the Centers for Medicare and Medicaid Innovation. BioNJ emphasizes that these proposed models could critically  more ST

WASHINGTON, March 1 -- The Blue Cross Blue Shield Association submitted a public comment letter to the U.S. Department of Health and Human Services expressing strong support for the agency's efforts toward enhancing price transparency in healthcare. This letter addresses the proposed rule regarding "Transparency in Coverage," published in the Federal Register in December. BCBSA, representing a national federation of independent and community-based Blue Cross and Blue Shield companies, emphasize more ST

WASHINGTON, March 1 -- The Cancer Leadership Council has issued a public comment letter to the Centers for Medicare & Medicaid Services expressing concerns regarding the proposed Global Benchmark for Efficient Drug Pricing (GLOBE) Model. The coalition, comprising various advocacy organizations dedicated to cancer care, has highlighted the potential adverse effects on the quality of care for cancer patients, particularly those relying on Medicare. The letter emphasizes that more than half of all more ST

WASHINGTON, March 1 -- The Council for Global Equality has submitted a public comment letter to the U.S. Department of Health and Human Services expressing strong opposition to a recently proposed rule which seeks to prohibit gender-affirming healthcare for minors. This proposed regulation, titled "Hospital Condition of Participation: Prohibiting Sex-Rejecting Procedures for Children," has sparked significant concern among advocates for LGBTQI+ rights. CGE, a prominent coalition of 45 U.S.-base more ST

WASHINGTON, March 1 -- The Child Welfare League of America, a coalition of child welfare organizations, has submitted a public comment letter to the Centers for Medicare & Medicaid Services urging the withdrawal of two proposed rules that could adversely affect transgender youth in foster care. The proposed rules, concerning Medicaid funding for sex-rejecting procedures and hospital participation conditions, have sparked widespread concern within the child welfare community. Since 1920, CWLA ha more ST

WASHINGTON, March 1 -- The Center for Individual Rights, a nonprofit public interest law firm, has submitted a public comment letter to the Centers for Medicare & Medicaid Services voicing strong opposition to the agency's proposed rule regarding gender-affirming care for minors. The proposed rule seeks to establish conditions under which hospitals participating in the Medicare program would be prohibited from offering "sex-rejecting procedures" for children under the age of 18. CIR, in a lette more ST

WASHINGTON, March 1 -- The Coalition Against Socialized Medicine has submitted a public comment letter to the Center for Medicare & Medicaid Services expressing strong opposition to the proposed Global Benchmark for Efficient Drug Pricing (GLOBE) model. The letter was issued in response to a notice published in the Federal Register on December 23, 2025, regarding docket #CMS-2025-1889. CASM, which is a coalition of various free-market and limited-government advocacy organizations, asserts that  more ST

WASHINGTON, March 1 -- AbbVie Inc., a biopharmaceutical company, has submitted a public comment letter to the Centers for Medicare & Medicaid Services expressing opposition to the proposed rules aimed at reforming Medicare drug pricing. The company highlighted significant concerns regarding the economic and legal implications of the proposed Global Benchmark for Efficient Drug Pricing (GLOBE) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) models. The proposed rules, issued on Dece more ST

WASHINGTON, March 1 -- Governing for Impact, a regulatory policy organization dedicated to enhancing federal government efficiency, has expressed strong opposition to a proposed rule from the Centers for Medicare and Medicaid Services (CMS) regarding treatments for minors with gender dysphoria. The public comment letter submitted to CMS outlines concerns that the proposed regulation, which seeks to prohibit certain medical services under the Medicare and Medicaid programs, would exceed the agenc more ST

WASHINGTON, March 1 -- The Competitive Enterprise Institute has submitted a public comment letter to the Centers for Medicare & Medicaid Services regarding the proposed Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model. In its communication, CEI expressed concerns about the potential impact of foreign price controls and evaluation systems on U.S. drug prices and availability for seniors. According to CEI, applying methodologies used by other nations to set U.S. drug prices could ha more ST

WASHINGTON, March 1 -- The County of Los Angeles has sent a public comment letter to the Centers for Medicare and Medicaid Services opposing proposed revisions to Medicare and Medicaid Conditions of Participation that would restrict access to gender-affirming care for minors. With a population exceeding 10 million, this largest county in the United States relies heavily on Medicare and Medicaid funding to ensure healthcare accessibility for its residents. In the detailed letter, the county's he more ST

WASHINGTON, March 1 -- Rising Starz, a child care provider based in D.C., has submitted a public comment letter to the U.S. Department of Health and Human Services (HHS) expressing strong opposition to the proposed rulemaking regarding changes to the Child Care and Development Fund (CCDF). The proposed rule (RIN 0970-AD20) seeks to shift reimbursement models from enrollment-based to attendance-based payments, a move that Rising Starz argues could destabilize the child care industry. In the lett more ST

WASHINGTON, March 1 -- Health Access California and the California LGBTQ Health and Human Services Network are calling on the Centers for Medicare & Medicaid Services to withdraw their public comment letter concerning a proposed amendment that seeks to prohibit hospitals from offering certain gender-affirming care for minors. The organizations argue that this proposed rule would restrict critical access to healthcare services, potentially endangering the well-being of affected youths and their f more ST

WASHINGTON, March 1 -- Intellia Therapeutics, a clinical-stage gene editing company, has submitted a public comment letter to the Centers for Medicare & Medicaid Services addressing their concerns regarding the proposed Global Benchmark for Efficient Drug Pricing Model (CMS-5545-P). This model's proposed exemption of cell and gene therapy products has particularly drawn concern from the organization, which is dedicated to developing innovative CRISPR-based therapies. In the letter, Intellia emp more ST

WASHINGTON, March 1 -- The Maryland Commission on LGBTQIA+ Affairs has submitted a public comment letter to the Centers for Medicare & Medicaid Services opposing the proposed rule CMS-3481-P. This regulation aims to prohibit certain medical procedures for children based on ideological grounds, and the Commission argues that it is both inappropriate and dangerous. The Commission, which is a state advisory body tasked with addressing challenges faced by LGBTQIA+ communities in Maryland, highlight more ST

WASHINGTON, March 1 -- Apiject Systems Corp., a medical technology company, submitted a public comment letter to the Centers for Medicare & Medicaid Services emphasizing the urgent requirement to bolster domestic pharmaceutical manufacturing, particularly in the context of the ongoing reliance on foreign production for generic injectable drugs. The letter highlights concerns regarding the structural dependency of the U.S. healthcare system on foreign production, with approximately 70-80 percent more ST

WASHINGTON, March 1 -- The Oregon Health Authority has submitted a public comment letter to the Centers for Medicare and Medicaid Services urging the federal agency to withdraw its proposed rule (CMS-3481-P) that seeks to prohibit sex-rejecting procedures for children. The OHA, tasked with enforcing Conditions of Participation (CoP) in healthcare settings, expressed concerns that the implementation of this proposed rule would impose significant harm on communities and disrupt access to critical  more ST

WASHINGTON, March 1 -- Arnold Ventures, a philanthropy dedicated to evidence-based policy solutions, has submitted a public comment letter to the Centers for Medicare and Medicaid Services regarding the proposed Global Benchmark for Efficient Drug Pricing Model (GLOBE Model). This proposed rule aims to address the high costs of prescription drugs within Medicare by establishing a framework designed to lower prices for high-cost brand-name drugs purchased through Medicare Part B. In the letter,  more ST

WASHINGTON, March 1 -- The National Association of Insurance Commissioners has submitted a public comment letter to the Centers for Medicare and Medicaid Services regarding proposed rules aimed at enhancing transparency in health insurance coverage. The proposed rule, published by the agency along with the Departments of Labor and Treasury, outlines measures to improve the disclosure of health insurance pricing and cost-sharing information. The proposed changes come as a response to ongoing con more ST

WASHINGTON, March 1 -- Santa Cruz Community Health Centers has submitted a public comment letter to the Centers for Medicare and Medicaid Services expressing strong opposition to a proposed rule that aims to prohibit hospitals participating in Medicare and Medicaid from providing certain gender-affirming medical care to individuals under the age of 18. The organization is urging the agency to withdraw this rule, citing potential harm to vulnerable youth and broader implications for the healthcar more ST

WASHINGTON, March 1 -- The City of Santa Monica has submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS), voicing strong opposition to proposed rules that would restrict gender-affirming healthcare for transgender, gender diverse, and intersex (TGI) youth. The city argues that these restrictions are harmful, unlawful, and directly conflict with local policies designed to protect TGI youth and their access to necessary healthcare services. Santa Monica, a city  more ST

WASHINGTON, March 1 -- The City Council of Solana Beach, California, has submitted a resolution as a public comment to the U.S. Department of the Interior expressing opposition to offshore oil and gas drilling along the California coastline. This resolution reflects the city's dedication to preserving its ocean waters and coastal habitats, which support a diverse range of wildlife including marine mammals, birds, and fish. In the resolution, the Solana Beach City Council unanimously emphasizes  more ST

WASHINGTON, March 1 -- The Susan G. Komen organization has issued a public comment letter to the Centers for Medicare & Medicaid Services (CMS) voicing concerns about the potential unintended consequences of the Global Benchmark for Efficient Drug Pricing (GLOBE) Model on breast cancer patients. While Komen recognizes the agency's efforts to alleviate the financial burden of cancer care, they urge that the model should not be finalized. As the leading nonprofit organization dedicated to breast  more ST

WASHINGTON, March 1 -- Trans Maryland, a community organization dedicated to the health and rights of transgender individuals, has submitted a public comment letter to the Centers for Medicare & Medicaid Services, urging the agency to withdraw its proposed rule titled "Medicare and Medicaid Programs; Hospital Condition of Participation: Prohibiting Sex-Rejecting Procedures for Children." The organization argues that the proposed rule represents an overreach of federal authority and threatens bot more ST

WASHINGTON, March 1 -- The U.S. Chamber of Commerce has submitted a public comment letter to the Centers for Medicare & Medicaid Services urging the agency to withdraw its proposed rules aimed at regulating drug pricing. These proposals, known as the Global Benchmark for Efficient Drug Pricing (GLOBE) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD), seek to establish price controls on a wide range of Medicare Part B and Part D prescription drugs. The Chamber opposes the proposals,  more ST